Fractyl Health announced that the company has received approval from the FDA for an Investigational Device Exemption (IDE) to begin its Revitalize-2 pivotal study.
[Fractyl Health, Inc.]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.